终止上市，600200，周三摘牌

Core Viewpoint - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (stock code: *ST Suwu) is set to be delisted from the Shanghai Stock Exchange, with the delisting process commencing on December 9, 2025, and concluding on December 31, 2025 [1][5]. Group 1: Delisting Process - The company's stock will enter a delisting transition period for 15 trading days, after which it will be officially delisted [1]. - Following the delisting, the company's stock will be transferred to the National Equities Exchange and Quotations (NEEQ) system for trading, managed by a designated securities company [2]. Group 2: Financial Misconduct - The company has been penalized for failing to disclose its actual controller and for falsifying financial reports from 2018 to 2023, including inflated revenue and profits [5]. - Specific financial discrepancies include inflated revenues of 49.53 million, 46.85 million, 43.07 million, and 37.67 million for the years 2020 to 2023, representing 26.46%, 26.39%, 21.26%, and 16.82% of reported revenues respectively [6]. - The company also failed to disclose significant non-operating fund occupations by related parties, with balances reaching 169.26 million by the end of 2023, which constituted 96.09% of the reported net assets [7].